GRAIL vs LifeStance Health Group

GRAIL (GRAL), health care, and LifeStance Health Group (LFST), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

LifeStance Health Group is worth $5.4B on the stock market and GRAIL $4.8B: LifeStance Health Group is valued at 13% more. GRAIL's operating margin in its latest fiscal year was -382% and LifeStance Health Group's 1.70%. Over the past year GRAIL's share price has moved +29.6% and LifeStance Health Group's +134%.

Key facts

GRAIL market value
$4.8B
LifeStance Health Group market value
$5.4B
LifeStance Health Group P/E
78.7
GRAIL revenue
$147.2MFY to 2025-12-31
LifeStance Health Group revenue
$1.4BFY to 2025-12-31
Superinvestors holding both
0

Market values as of .

GRAIL vs LifeStance Health Group: every measure side by side
Measure GRAIL LifeStance Health Group
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$4.8Blower$5.4Bhigher
Revenue$147.2Mlower$1.4Bhigher
Earnings-$408.4Mlower$9.7Mhigher
Employees910lower8,863higher
Total assets$2.9Bhigher$2.2Blower
Valuation
P/E—78.7
P/S32.3higher3.8lower
P/B1.9lower3.6higher
Dividend yield0.00%0.00%
Profitability
Operating margin-382%lower1.70%higher
Balance sheet
Net assets$2.6Bhigher$1.5Blower
Total liabilities$344.2Mlower$682.9Mhigher
Total debt—$282.8M
Cash on hand$249.7Mhigher$248.6Mlower
Price change
Today+0.27%higher-2.14%lower
1 year+29.6%lower+134%higher

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (0)

None of the tracked investors.

LifeStance Health Group only (1)

Percentages are each holding's share of that investor's reported portfolio. Who owns GRAL · Who owns LFST

Further comparisons

Learn

Questions and answers

Which is bigger, GRAIL or LifeStance Health Group?

By market value, LifeStance Health Group is the larger: $5.4B against $4.8B for GRAIL. By revenue in its latest fiscal year, LifeStance Health Group is the larger: $1.4B against $147.2M for GRAIL.

Which has the higher operating margin?

LifeStance Health Group: 1.70%, against -382% for GRAIL. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both GRAIL and LifeStance Health Group?

None of the tracked superinvestors holds both in their latest 13F filing. 3 hold GRAIL and 1 holds LifeStance Health Group.

Cite this page

Funkfolio, “GRAIL vs LifeStance Health Group”, data as of 18 November 2026. https://funkfolio.com/compare/gral-vs-lfst

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.